IL13 and neoplasm: In some cancers, including breast 72, gastric 73 and pancreatic cancer 74, 75, Th2 cells and associated cytokines [IL‐4, IL‐13, Thymic stromal lymphopoietin (TSLP)] contribute to tumour progression.